<code id='27EC9F9283'></code><style id='27EC9F9283'></style>
    • <acronym id='27EC9F9283'></acronym>
      <center id='27EC9F9283'><center id='27EC9F9283'><tfoot id='27EC9F9283'></tfoot></center><abbr id='27EC9F9283'><dir id='27EC9F9283'><tfoot id='27EC9F9283'></tfoot><noframes id='27EC9F9283'>

    • <optgroup id='27EC9F9283'><strike id='27EC9F9283'><sup id='27EC9F9283'></sup></strike><code id='27EC9F9283'></code></optgroup>
        1. <b id='27EC9F9283'><label id='27EC9F9283'><select id='27EC9F9283'><dt id='27EC9F9283'><span id='27EC9F9283'></span></dt></select></label></b><u id='27EC9F9283'></u>
          <i id='27EC9F9283'><strike id='27EC9F9283'><tt id='27EC9F9283'><pre id='27EC9F9283'></pre></tt></strike></i>

          explore

          explore

          author:Wikipedia    Page View:7
          translucent 3D DNA helix with blue and purple background
          Adobe

          Verve Therapeutics said Monday that it had received clearance from the Food and Drug Administration to conduct a clinical trial in the U.S. of its experimental, gene-editing treatment for a common form of heart disease.

          The FDA’s action removes a clinical hold on Verve’s CRISPR-based therapy, called VERVE-101, that was placed on it last November. Verve now intends to recruit participants from U.S. sites into a Phase 1 study that’s been underway since last year in New Zealand and the United Kingdom.

          advertisement

          “We’re thrilled to get this clearance for VERVE-101,” said Verve CEO Sek Kathiresan. “Our study is called HEART-1 and our plan now is to activate U.S. sites.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          The pain doctors face in trying to build their families
          The pain doctors face in trying to build their families

          Adobe“TheRetrievals,”adisturbingpodcastfromSerialandtheNewYorkTimesreleasedthissummer,painstakinglyt

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more

          CDC recommends rationing of RSV shot due to shortages

          Inanewhealthalert,theCDCsaidcliniciansshouldprioritizeavailableBeyfortusdosesforbabiesathighestriskf